Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
29 Despite these insights, DDR-targeted therapies remain challenged by nonselective toxicity, resistance heterogeneity, limited biomarker availability and modest clinical durability
Diabetic wounds represent particularly challenging healing scenarios, making these results especially significant
Addressing this accumulated damage requires regenerative processes the peptide appears to stimulate
Gonzlez-Domnguez et al., 2014
MichelsLSchulte-VelsTSchickMO'GormanRLZeffiroTHaslerGet al
US$ 29.47
US$ 20.91
US$ 22.58
